All research papers

Analysis Method of 131 I Activity in Carbon Cartridge and Internal Dose Assessment for Nuclear Medicine Workers.

Radiopharmaceuticals and their applications in medicine.

Dosimetric and Radiobiological Impact of Patient Setup Errors in Intensity-modulated Radiotherapy for Esophageal Cancer.

Does deformation of immobilization devices impact treatment accuracy in thoracic cancer radiotherapy?

Efficacy of a thermoplastic mask and pneumatic abdominal compression device for immobilization in stereotactic ablative radiotherapy of spine metastases.

Commissioning a clinical proton pencil beam scanning beamline for pre-clinical ultra-high dose rate irradiations on a cyclotron-based system.

Impact of belly board immobilization devices and body mass factor on setup displacement using daily cone-beam CT in rectal cancer radiotherapy.

Sentinel Lymph Node Detection in Early-Stage Oral Squamous Cell Carcinoma Using Magnetic Resonance Lymphography: A Pilot Study.

Urease-powered nanomotor containing STING agonist for bladder cancer immunotherapy.

Design and development of nanoprobes radiolabelled with 99m Tc for the diagnosis and monitoring of therapeutic interventions in oncology preclinical research.

Chronic Low-Dose-Rate Radiation-Induced Persistent DNA Damage and miRNA/mRNA Expression Changes in Mouse Hippocampus and Blood.

Use of Radioguided Surgery for Small and Difficult-to-Locate Relapsed MIBG (+) High-Risk Neuroblastoma Lesions.

High buttocks supine position to reduce small bowel exposure in gynecological radiotherapy.

Study protocol: Optimising patient positioning for the planning of accelerated partial breast radiotherapy for the integrated magnetic resonance linear accelerator: OPRAH MRL.

¹⁷⁷Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial.

Use of real-time electronic extremity dosimeters for monitoring and optimisation of radiopharmacy technique.

Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy.

A prospective observational study evaluating two patient immobilisation methods in lung stereotactic radiotherapy.

[¹⁷⁷Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study.

Evaluating the Radioactive Waste Produced per Patient by Radiopharmaceutical Sources and Measuring the Radioactive Contamination of Surfaces and Staff at the Bushehr Nuclear Medicine Department.

Real-time gated proton therapy with a reduced source to imager distance: Commissioning and quality assurance.

Covalent targeted radioligands potentiate radionuclide therapy.

Eligibility of a novel BW + technology and comparison of sensitivity and specificity of different imaging methods for radiological caries detection.

Comparison of the performance of two thermoluminescent dosimetry systems for the personal dose-equivalent Hp(10) measurement.

Evaluation of the effect of sagging correction calibration errors in radiotherapy software on image matching.

Urease-powered nanobots for radionuclide bladder cancer therapy.

Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study.

Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study.

Single isocenter HyperArc treatment of multiple intracranial metastases: Targeting accuracy.

Overall survival with [¹⁷⁷Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial.

3BP-3940, a highly potent FAP-targeting peptide for theranostics - production, validation and first in human experience with Ga-68 and Lu-177.

Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiation Therapy in Patients with Pancreatic Cancer.

Preparation, Radiolabeling with ⁶⁸Ga/¹⁷⁷Lu and Preclinical Evaluation of Novel Angiotensin Peptide Analog: A New Class of Peptides for Breast Cancer Targeting.

Fully automated radiolabeling of [⁶⁸Ga]Ga-EMP100 targeting c-MET for PET-CT clinical imaging.

Phase I clinical evaluation of 99m Tc-labeled Affibody molecule for imaging HER2 expression in breast cancer.

Simultaneous photon counting and charge integrating for pulse pile-up correction in paralyzable photon counting detectors.

AAPM Task Group Report 307: Use of EPIDs for Patient-Specific IMRT and VMAT QA.

Functional PET Neuroimaging in Consciousness Evaluation: Study Protocol.

ESTRO-ACROP guideline: Recommendations on implementation of breath-hold techniques in radiotherapy.

Clinical and dosimetric factors for symptomatic radiation pneumonitis after stereotactic body radiotherapy for early-stage non-small cell lung cancer.

Joint EANM/SNMMI procedure guideline for the use of ¹⁷⁷Lu-labeled PSMA-targeted radioligand-therapy (¹⁷⁷Lu-PSMA-RLT).

FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer.

Sentinel node-assisted neck dissection in advanced oral squamous cell carcinoma-A new protocol for staging and treatment.

Feasibility and Safety of Tailored Lymphadenectomy Using Sentinel Node-Navigated Surgery in Patients with High-Risk T1 Esophageal Adenocarcinoma.

Occupational exposure to ionizing radiation in medical staff: trends during the 2009-2019 period in a multicentric study.

Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2).

Toxicity, quality of life, and PSA control after 50 Gy stereotactic body radiation therapy to the dominant intraprostatic nodule with the use of a rectal spacer: results of a phase I/II study.

Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies.

Implementation of superficial radiation therapy (SRT) using SRT-100 Vision™ for non-melanoma skin cancer in a Radiation Oncology clinic.

Radiolysis-Associated Decrease in Radiochemical Purity of ¹⁷⁷Lu-Radiopharmaceuticals and Comparison of the Effectiveness of Selected Quenchers against This Process.

Automated synthesis and quality control of [⁶⁸Ga]Ga-PentixaFor using the Gaia/Luna Elysia-Raytest module for CXCR4 PET imaging.

Sentinel Lymph Node Procedure in Pediatric Patients with Melanoma, Squamous Cell Carcinoma, or Sarcoma Using Near-Infrared Fluorescence Imaging with Indocyanine Green: A Feasibility Trial.

PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.

Main challenges in radiation protection with emerging radionuclide therapies.

FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease.

A preclinical model to investigate normal tissue damage following fractionated radiotherapy to the head and neck.

Comprehensive Analysis of Fibroblast Activation Protein Expression in Interstitial Lung Diseases.

Machine performance and stability of the first clinical self-shielded stereotactic radiosurgery system: Initial 2-year experience.

Preliminary Screening of Soils Natural Radioactivity and Metal(loid) Content in a Decommissioned Rare Earth Elements Processing Plant, Guangdong, China.

Evaluation of setup errors of immobilization device for radiation therapy in companion animals.